A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque Psoriasis; OASIS-1

Press/Media: Press / Media

Period2018 Oct 2

Media coverage

1

Media coverage

  • TitleA Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque Psoriasis; OASIS-1
    Media name/outletClinical Trials.gov
    Country/TerritoryUnited States
    Date18/10/2
    PersonsHyun Mee Kim, Jong Hyeok Park
View all 1
View less